Suchergebnisse - "Trifluridine"

PubPharm (969)

1

Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment

enthalten in: Journal of translational medicine | 2024

von Ottaiano, A. | Santorsola, M. | Ianniello, M. | +13

2

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting : a multicenter, prospective, observational study

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Fujii, H. | Tsuchiya, M. | Watanabe, D. | +22

3

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study

enthalten in: Supportive care in cancer | 2024

von Fujii, H. | Tsuchiya, M. | Watanabe, D. | +22

4

Anti-EGFR Rechallenge in Patients With Refractory ctDNA RAS/BRAF wt Metastatic Colorectal Cancer : A Nonrandomized Controlled Trial

enthalten in: JAMA network open | 2024

von Ciardiello, D. | Martinelli, E. | Troiani, T. | +19

5

Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer

enthalten in: Anticancer research | 2024

von Hara, S. | Sakai, D. | Ikemura, K. | +4

6

Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer : An Updated Systematic Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2024

von Azeredo-da-Silva, A. | de Jesus, V. | Agirrezabal, I. | +7

7

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer : WJOG 11018G

enthalten in: Targeted oncology | 2024

von Matsumoto, T. | Yamamoto, Y. | Kotaka, M. | +19

8

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer : post hoc analysis of the phase III SUNLIGHT trial

enthalten in: ESMO open | 2024

von Tabernero, J. | Taieb, J. | Fakih, M. | +8

9

A Phase 1 Study of Cabozantinib and Trifluridine/Tipiracil in Metastatic Colorectal Adenocarcinoma

enthalten in: Clinical colorectal cancer | 2024

von Dayyani, F. | Balangue, J. | Valerin, J. | +4

10

A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients

enthalten in: International journal of cancer | 2024

von Lee, V. | Parkinson, R. | Zahurak, M. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[97]